Stanley Black & Decker announces key leadership changes, appointing a new General Counsel and adding fresh expertise to its board. The moves signal a deeper focus on governance and operational oversight as the company navigates its financial turnaround.
A Wells Fargo upgrade highlights ConocoPhillips' robust cash flow trajectory and strategic projects, positioning the energy giant for significant dividend growth over the next five years.
U.S. immigration authorities will not conduct enforcement actions at this Sunday's Super Bowl, sources tell Reuters, as the event becomes a flashpoint in the nation's heated immigration debate.
The Hennepin County Medical Examiner has ruled the death of Alex Pretti, a 37-year-old nurse shot by federal agents during a Minneapolis immigration protest, a homicide by multiple gunshot wounds, as witness accounts and footage challenge the official narrative of the incident.
Vera Therapeutics appoints industry veteran Matt Skelton as Chief Commercial Officer, signaling a strategic pivot toward commercialization as its lead drug candidate for IgA nephropathy, atacicept, undergoes FDA Priority Review.
Kemper Corporation is set to report its fourth-quarter earnings Wednesday afternoon, with investors watching closely for signs of stability after a period of mixed performance and sector-wide pressure.
As Equitable Holdings prepares to report fourth-quarter results, investors are watching for signs of stability amid a turbulent period for insurance stocks. With revenue growth expected to stall, the focus shifts to profitability and guidance.
Offshore drilling contractor Noble Corporation bolsters its forward workload with a series of new multi-year contracts totaling approximately $1.3 billion, headlined by a major harsh-environment rig award in Norway, signaling a strategic geographic expansion and renewed confidence in the offshore cycle.
The pharmaceutical giant is set to release quarterly results before the bell Wednesday, with Wall Street anticipating another period of blockbuster revenue growth driven by its GLP-1 drugs.
Aerospace and defense component maker Woodward, Inc. (WWD) is commanding investor attention following a robust first-quarter earnings beat, a significant dividend hike, and an upgraded full-year outlook. The strong results have propelled the stock to new highs, reigniting the debate over its valuation in a rapidly evolving industry.
The global insurer faces heightened scrutiny after a recent revenue miss, with analysts projecting a sharp year-over-year sales increase as peers post mixed results.
GE HealthCare Technologies prepares to release its fourth-quarter financial results amid steady analyst expectations and a mixed performance landscape for medical equipment peers.
Old Dominion Freight Line prepares to release its quarterly results Wednesday morning, with analysts projecting a revenue dip but watching for signs of resilience in a challenging transport market.
Crown Holdings (CCK) is scheduled to report its fourth-quarter earnings after Wednesday's market close, with analysts projecting modest revenue growth and steady profitability as the metal packaging giant navigates shifting demand and competitive pressures.
As Evercore prepares to report fourth-quarter results, analysts anticipate steady revenue growth. The firm's consistent history of beating estimates and the performance of its peers set the stage for a closely watched announcement.
All eyes are on healthcare giant McKesson as it prepares to report fourth-quarter results. With a history of revenue misses and a slowing growth rate, analysts and investors are keen to see if the company can deliver a positive surprise.
Globe Life (NYSE: GL) is set to report its fourth-quarter earnings after the market closes on Wednesday. With the insurance sector facing headwinds, investors are watching to see if the company can deliver growth that outpaces its recent history of revenue misses.
Monarch Casinos & Resorts (MCRI) will release its fourth-quarter financial results after Wednesday's market close, with analysts projecting modest revenue growth but heightened scrutiny on its high-end gaming segment performance.
Fox Corporation (NASDAQ: FOXA) is scheduled to release its fourth-quarter financial results Wednesday morning, with analysts anticipating steady revenue but slower growth compared to last year's surge.
Medical device giant Boston Scientific (BSX) is scheduled to release its fourth-quarter financial results before market open on Wednesday, with Wall Street anticipating continued strong revenue growth and another potential earnings beat.
